View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 15, 2020

Covid-19 third most funded infectious disease over past five years

By Allie Nawrat

Using data from the World Health Organisation and Policy Cure Research, UK-based RIFT Research and Development has concluded that, based on average annual funding over the past five years, Covid-19 is the third most funded infectious disease.

In the past three and a half months, £332.4m has been pledged to fight Covid-19. Whereas the average annual funding over the past five years totalled £936.9m for HIV and £471.1m for tuberculosis.

In addition, in terms of total funding over the past five years, only five infectious diseases have received more funding than Covid-19: HIV, tuberculosis, two types of malaria and Dengue.

RIFT Research and Development director Sarah Collins commented: “Anyone in any doubt over the seriousness of the current pandemic need only look at the sheer level of funding already committed in the fight against it.

“It is really quite staggering that in just three and a half short months, funding in the fight against Covid-19 has eclipsed total funding in the last five years for all but five other diseases.

“Only time will tell if this huge level of funding will be required on a long-term basis, and more importantly, if it will make the required impact.”

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy